Biokemisk diagnostik vid alzheimerdemens

Lakartidningen

Volumn 93, Issue 24, 1996, Pages 2326-2331

  Lannfelt, Lars ^a   Jensen, Malene ^a   Froelich, Susanne ^a   Basun, Hans ^a   Näslund, Jan ^a   Nordstedt, Christer ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; BIOLOGICAL MODEL; CULTURE TECHNIQUE; GENETICS; HUMAN; METABOLISM; MUTATION; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; CELL CULTURE TECHNIQUES; HUMANS; MODELS, GENETIC; MUTATION; RISK FACTORS;

EID: 0030580885     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131-5.
2. Basun H, Lannfelt L. Alzheimers sjukdom. Stora steg framåt i kunskap om orsak trots brist på behandling och markörer. Läkartidningen 1995; 92: 419-20.
3. Sjögren T, Sjögren H, Lindgren ÅGH. Morbus Alzheimer and Morbus Pick. A genetic, clinical and patho-anatomical study. Acta Psychiatr Scand 1952; suppl 82.
4. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1992; 1: 345-7.
5. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754-60.
6. Van Broeckhoven C. Presenilins and Alzheimer disease. Nat Genet 1995; 11: 230-2.
7. Clark RF, Hutton M, Fuldner RA, Froelich S, Karran E, Talbot C et al. The structure of the Presenilin I (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995; 11: 219-22.
8. Lannfelt L, Basun H, Winblad B. Alzheimers sjukdom. Starkt samband mellan apolipoprotein E och Alzheimers sjukdom. Läkartidningen 1994; 91: 1500-2.
9. Lannfelt L, Lilius L, Nastase M, Viitanen M, Fratiglioni L, Eggertsen G et al. Lack of association between apolipoprotein E allele ε4 and sporadic Alzheimer's disease. Neurosci Lett 1994; 169: 175-8.
10. Näslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlström AR, Bogdanovic N et al. Aβ and apolipoprotein E complexes from Alzheimer disease brain: purification and structural characterization. Neuron 1995; 15: 219-28.
11. Nordstedt C, Caporaso GL, Thyberg J, Gandy SE, Greengard P. Identification of the Alzheimer β/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC 12 cells. J Biol Chem 1993; 268: 608-12.
12. Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnston J et al. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc Natl Acad Sci USA 1994; 91: 11993-7.
13. Johnston JA, Cowburn RF, Norgren S, Wiehager B, Venizelos N, Winblad B et al. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP6701/671 mutation. FEBS Lett 1994; 354: 274-8.
14. Näslund J, Jensen M, Tjernberg LO, Thyberg J, Terenius L, Nordstedt C. The metabolic pathway generating p3, an Aβ fragment, is probably non-amyloidogenic. Biochem Biophys Res Commun 1994; 204: 780-7.
15. Cummings BJ, Cotman CW. Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia. Lancet 1995; 346: 1524-7.
16. Lannfelt L, Basun H, Vigo-Pelfrey C, Wahlund LO, Winblad B, Lieberburg I et al. Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neurosci Lett 1995; 199: 203-6.
17. Jensen M, Basun H, Lannfelt L. Increased cerebrospinal fluid tau in patients with Alzheimer's disease. Neurosci Lett 1995; 186: 189-91.
18. Wallin A. Konsensus om demenssjukdomar (I): Klassifikation och utredning. Läkartidningen 1990; 87: 3856-65.
19. Lannfelt L, Basun B, Wahlund LO, Rowe BM, Wagner S. Decreased cerebrospinal fluid α-secretase cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat Med 1995; 1: 829-32.